Revisiting Thyroid Hormones in Schizophrenia

Thyroid hormones are crucial during development and in the adult brain. Of interest, fluctuations in the levels of thyroid hormones at various times during development and throughout life can impact on psychiatric disease manifestation and response to treatment. Here we review research on thyroid function assessment in schizophrenia, relating interrelations between the pituitary-thyroid axis and major neurosignaling systems involved in schizophrenia's pathophysiology. These include the serotonergic, dopaminergic, glutamatergic, and GABAergic networks, as well as myelination and inflammatory processes. The available evidence supports that thyroid hormones deregulation is a common feature in schizophrenia and that the implications of thyroid hormones homeostasis in the fine-tuning of crucial brain networks warrants further research.

[1]  Brian Kirkpatrick,et al.  Inflammation and schizophrenia. , 2013, Schizophrenia bulletin.

[2]  A. Rodrigues,et al.  Mechanisms of initiation and reversal of drug-seeking behavior induced by prenatal exposure to glucocorticoids , 2012, Molecular Psychiatry.

[3]  G. D. de Escobar,et al.  Psychomotor development of children from an iodine-deficient region. , 2011, The Journal of pediatrics.

[4]  N. Sousa,et al.  Programming effects of antenatal corticosteroids exposure in male sexual behavior. , 2011, The journal of sexual medicine.

[5]  B. Capuano,et al.  Schizophrenia: a systematic review of the disease state, current therapeutics and their molecular mechanisms of action. , 2011, Current medicinal chemistry.

[6]  H. Meltzer,et al.  The role of serotonin receptors in the action of atypical antipsychotic drugs. , 2011, Current opinion in pharmacology.

[7]  O. Ahmed,et al.  Effects of experimentally induced maternal hypothyroidism and hyperthyroidism on the development of rat offspring: I. The development of the thyroid hormones–neurotransmitters and adenosinergic system interactions , 2010, International Journal of Developmental Neuroscience.

[8]  S. Sabeen,et al.  Abnormal thyroid stimulating hormone (TSH) in psychiatric long-term care patients. , 2010, Archives of gerontology and geriatrics.

[9]  P. Davis,et al.  Molecular aspects of thyroid hormone actions. , 2010, Endocrine reviews.

[10]  D. Javitt Glutamatergic theories of schizophrenia. , 2010, The Israel journal of psychiatry and related sciences.

[11]  W. Wiersinga Do we need still more trials on T4 and T3 combination therapy in hypothyroidism? , 2009, European journal of endocrinology.

[12]  A. Nica,et al.  Hyperthyroidism–cause of depression and psychosis: a case report , 2009, Journal of medicine and life.

[13]  G. Van den Berghe,et al.  The hypothalamus-pituitary-thyroid axis in critical illness. , 2009, The Netherlands journal of medicine.

[14]  R. Bunevic̆ius Thyroid disorders in mental patients , 2009, Current opinion in psychiatry.

[15]  Susumu Mori,et al.  Abnormal expression of myelination genes and alterations in white matter fractional anisotropy following prenatal viral influenza infection at E16 in mice , 2009, Schizophrenia Research.

[16]  P. Masand,et al.  Thyroid hormones affect recovery from depression during antidepressant treatment , 2009, Psychiatry and clinical neurosciences.

[17]  V. Sridama,et al.  Psychosis as the first presentation of hyperthyroidism , 2009, Internal and Emergency Medicine.

[18]  Angus W MacDonald,et al.  What we know: findings that every theory of schizophrenia should explain. , 2009, Schizophrenia bulletin.

[19]  B. Dean,et al.  Recent advances in postmortem pathology and neurochemistry in schizophrenia , 2009, Current opinion in psychiatry.

[20]  T. Scanlan 3-Iodothyronamine (T1AM): A New Player on the Thyroid Endocrine Team? , 2009 .

[21]  T. Schmitz,et al.  Cytokines and Myelination in the Central Nervous System , 2008, TheScientificWorldJournal.

[22]  C. Tasca,et al.  Thyroid hormone increases astrocytic glutamate uptake and protects astrocytes and neurons against glutamate toxicity , 2008, Journal of neuroscience research.

[23]  K. Davis,et al.  Abnormal Indices of Cell Cycle Activity in Schizophrenia and their Potential Association with Oligodendrocytes , 2008, Neuropsychopharmacology.

[24]  A. Ray,et al.  Thyroid Hormone Homeostasis in Brain: Possible Involvement of Adrenergic Phenomenon in Adult Rat , 2008, Neuroendocrinology.

[25]  Franz X Vollenweider,et al.  Serotonin research: contributions to understanding psychoses. , 2008, Trends in pharmacological sciences.

[26]  D. Forrest,et al.  Multigenic control of thyroid hormone functions in the nervous system , 2008, Molecular and Cellular Endocrinology.

[27]  Emmanuel Stip,et al.  Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review , 2008, Biological Psychiatry.

[28]  O. Ahmed,et al.  Thyroid hormones states and brain development interactions , 2008, International Journal of Developmental Neuroscience.

[29]  S. Bahn,et al.  Cerebrospinal fluid: identification of diagnostic markers for schizophrenia , 2008, Expert review of molecular diagnostics.

[30]  G. Anderson Thyroid hormone and cerebellar development , 2007, The Cerebellum.

[31]  G. D. de Escobar,et al.  Iodine deficiency and brain development in the first half of pregnancy , 2007, Public Health Nutrition.

[32]  W. Wiersinga,et al.  Interleukin-1β modulates endogenous thyroid hormone receptor α gene transcription in liver cells , 2007 .

[33]  B. Barres,et al.  A Crucial Role for p57Kip2 in the Intracellular Timer that Controls Oligodendrocyte Differentiation , 2007, The Journal of Neuroscience.

[34]  M. Frye,et al.  Free T4 index and clinical outcome in patients with depression. , 2007, Journal of affective disorders.

[35]  J. Bernal Thyroid hormone receptors in brain development and function , 2007, Nature Clinical Practice Endocrinology &Metabolism.

[36]  M. Arufe,et al.  Endogenous excitatory amino acid neurotransmission regulates thyroid-stimulating hormone and thyroid hormone secretion in conscious freely moving male rats , 2002, Endocrine.

[37]  Anissa Abi-Dargham,et al.  Alterations of serotonin transmission in schizophrenia. , 2007, International review of neurobiology.

[38]  J. Romaldini,et al.  Subclinical hypothyroidism increases the risk for depression in the elderly. , 2007, Archives of gerontology and geriatrics.

[39]  G. Chiellini,et al.  Trace amine‐associated receptors and their ligands , 2006, British journal of pharmacology.

[40]  T. Speed,et al.  Functional Genomic Analysis of Oligodendrocyte Differentiation , 2006, The Journal of Neuroscience.

[41]  S. Akbarian,et al.  Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders , 2006, Brain Research Reviews.

[42]  Elaine Holmes,et al.  Metabolic Profiling of CSF: Evidence That Early Intervention May Impact on Disease Progression and Outcome in Schizophrenia , 2006, PLoS medicine.

[43]  V. Trudeau,et al.  Thyroid hormone and γ-aminobutyric acid (GABA) interactions in neuroendocrine systems ☆ , 2006 .

[44]  A. Hofman,et al.  Thyroid hormones, dementia, and atrophy of the medial temporal lobe. , 2006, The Journal of clinical endocrinology and metabolism.

[45]  J. Palha,et al.  Thyroid hormones and retinoids: A possible link between genes and environment in schizophrenia , 2006, Brain Research Reviews.

[46]  C. Kripper,et al.  [High prevalence of thyroid dysfunction among psychiatric inpatients]. , 2006, Revista medica de Chile.

[47]  A. Trentin Thyroid hormone and astrocyte morphogenesis. , 2006, The Journal of endocrinology.

[48]  R. Milev,et al.  T3 augmentation of SSRI resistant depression. , 2006, Journal of affective disorders.

[49]  S. Snyder,et al.  Dopamine Receptor Excess and Mouse Madness , 2006, Neuron.

[50]  A. Carlsson The Neurochemical Circuitry of Schizophrenia , 2006, Pharmacopsychiatry.

[51]  G. Kaprinis,et al.  Peripheral thyroid dysfunction in depression , 2006, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[52]  W. Wiersinga,et al.  Induction of type 3 deiodinase activity in inflammatory cells of mice with chronic local inflammation. , 2005, Endocrinology.

[53]  Martin Telefont,et al.  Transient maternal hypothyroxinemia at onset of corticogenesis alters tangential migration of medial ganglionic eminence‐derived neurons , 2005, The European journal of neuroscience.

[54]  D. Lewis,et al.  Cortical inhibitory neurons and schizophrenia , 2005, Nature Reviews Neuroscience.

[55]  J. Tijssen,et al.  Thyroid and adrenal axis in major depression: a controlled study in outpatients. , 2005, European journal of endocrinology.

[56]  R. Conley,et al.  Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine. , 2005, The Journal of clinical psychiatry.

[57]  C. Carella,et al.  Increased cerebrospinal fluid levels of 3,3',5'-triiodothyronine in patients with Alzheimer's disease. , 2005, The Journal of clinical endocrinology and metabolism.

[58]  M. Obregon,et al.  Role of thyroid hormone during early brain development. , 2004, European journal of endocrinology.

[59]  R. Zoeller,et al.  Timing of Thyroid Hormone Action in the Developing Brain: Clinical Observations and Experimental Findings , 2004, Journal of neuroendocrinology.

[60]  P. Berbel,et al.  A moderate and transient deficiency of maternal thyroid function at the beginning of fetal neocorticogenesis alters neuronal migration. , 2004, Endocrinology.

[61]  G. D. de Escobar,et al.  Maternal thyroid hormones early in pregnancy and fetal brain development. , 2004, Best practice & research. Clinical endocrinology & metabolism.

[62]  Sabina Frascarelli,et al.  3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone , 2004, Nature Medicine.

[63]  R. Goodyear,et al.  Hearing loss and retarded cochlear development in mice lacking type 2 iodothyronine deiodinase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[64]  Saint-Clair Bahls,et al.  [The relation between thyroid function and depression: a review]. , 2004, Revista brasileira de psiquiatria.

[65]  J. Strawn,et al.  Pituitary-Thyroid State Correlates with Central Dopaminergic and Serotonergic Activity in Healthy Humans , 2004, Neuropsychobiology.

[66]  D. Overstreet,et al.  Modification of the behavioural effects of haloperidol and of dopamine receptor regulation by altered thyroid status , 1983, Psychopharmacology.

[67]  G. Huber,et al.  Altered interrelationship of dopamine, prolactin, thyrotropin and thyroid hormone in schizophrenic patients , 2004, European archives of psychiatry and neurological sciences.

[68]  A. Contestabile,et al.  Temporal, regional and cellular selectivity of neonatal alteration of the thyroid state on neurochemical maturation in the rat , 2004, Experimental Brain Research.

[69]  Tao Li,et al.  The genetics of schizophrenia: glutamate not dopamine? , 2003, European journal of pharmacology.

[70]  R. Chaube,et al.  Thyroid hormone modulation of brain in vivo tyrosine hydroxylase activity and kinetics in the female catfish Heteropneustes fossilis. , 2003, The Journal of endocrinology.

[71]  F. Trimarchi,et al.  Don't forget the thyroid in the etiology of psychoses. , 2003, The American journal of medicine.

[72]  Philip D. Harvey,et al.  White matter changes in schizophrenia: evidence for myelin-related dysfunction. , 2003, Archives of general psychiatry.

[73]  P. Berbel,et al.  Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny. , 2003, The Journal of clinical investigation.

[74]  J. de Leon,et al.  Glucuronidation enzymes, genes and psychiatry. , 2003, The international journal of neuropsychopharmacology.

[75]  S. Kapur Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. , 2003, The American journal of psychiatry.

[76]  Y. Chan,et al.  Thyroid dysfunction in chronic schizophrenia within a state psychiatric hospital. , 2002, Annals of the Academy of Medicine, Singapore.

[77]  A. Yazıcı,et al.  Different neuroendocrine profiles of remitted and nonremitted schizophrenic patients , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[78]  A. Heinz,et al.  Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain , 2002, Molecular Psychiatry.

[79]  M. Frye,et al.  Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature. , 2001, The American journal of psychiatry.

[80]  W H Wong,et al.  Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[81]  M. Eriksson,et al.  Depressive Symptoms in Hypothyroid Disorder with some Observations on Biochemical Correlates , 2001, Neuropsychobiology.

[82]  Sarah Kotchen Rack,et al.  Hypothyroidism and Depression: A Therapeutic Challenge , 2000, The Annals of pharmacotherapy.

[83]  W. Gaebel,et al.  The hypothalamic–pituitary–thyroid axis in patients with schizophrenia , 2000, Schizophrenia Research.

[84]  M. Kilby,et al.  Thyroid hormone and central nervous system development. , 2000, The Journal of endocrinology.

[85]  G. Pinna,et al.  Printed in U.S.A. Copyright © 2000 by The Endocrine Society Effects of Pharmacological and Nonpharmacological Treatments on Thyroid Hormone Metabolism and Concentrations in Rat Brain* , 1999 .

[86]  N. Marsh-Armstrong,et al.  Asymmetric Growth and Development of the Xenopus laevis Retina during Metamorphosis Is Controlled by Type III Deiodinase , 1999, Neuron.

[87]  J. Ayuso-Mateos,et al.  Evaluation of thyroid function in lithium-naive bipolar patients , 1999, European Psychiatry.

[88]  Marc G Caron,et al.  Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia , 1999, Cell.

[89]  M. Laruelle,et al.  Increased dopamine transmission in schizophrenia: relationship to illness phases , 1999, Biological Psychiatry.

[90]  R. Jeanningros,et al.  Effects of Experimental Hypothyroidism on 5-HT1A, 5-HT2A Receptors, 5-HT Uptake Sites and Tryptophan Hydroxylase Activity in Mature Rat Brain , 1999, Neuroendocrinology.

[91]  L. Chiovato,et al.  Prevalence of Psychiatric Disorders in Thyroid Diseased Patients , 1998, Neuropsychobiology.

[92]  R. Chapell,et al.  Direct channel-gating and modulatory effects of triiodothyronine on recombinant GABA(A) receptors. , 1998, European journal of pharmacology.

[93]  J. Faber,et al.  The role of thyroid hormones in depression. , 1998, European journal of endocrinology.

[94]  P. Sullivan,et al.  The hypothalamic‐pituitary‐thyroid axis in major depression , 1997, Acta psychiatrica Scandinavica.

[95]  N. Ibarrola,et al.  Hypothyroidism coordinately and transiently affects myelin protein gene expression in most rat brain regions during postnatal development , 1997, Brain Research.

[96]  G. Aghajanian,et al.  The role of serotonin in the pathophysiology and treatment of schizophrenia. , 1997, The Journal of neuropsychiatry and clinical neurosciences.

[97]  H. Möller,et al.  Low plasma thyroid indices of depressed patients are attenuated by antidepressant drugs and influence treatment outcome. , 1996, Pharmacopsychiatry.

[98]  C. Naylor,et al.  Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis. , 1996, Archives of general psychiatry.

[99]  J. Krystal,et al.  Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[100]  M. Dratman,et al.  Immunohistochemical mapping of brain triiodothyronine reveals prominent localization in central noradrenergic systems , 1996, Neuroscience.

[101]  J. V. Martin,et al.  Thyroid hormonal modulation of the binding and activity of the GABAA receptor complex of brain , 1996, Neuroscience.

[102]  A. Cleare,et al.  Thyroxine replacement increases central 5-hydroxytryptamine activity and reduces depressive symptoms in hypothyroidism. , 1996, Neuroendocrinology.

[103]  I. Hickie,et al.  Clinical and Subclinical Hypothyroidism in Patients with Chronic and Treatment-Resistant Depression , 1996, The Australian and New Zealand journal of psychiatry.

[104]  J. DeFelipe,et al.  Distribution of parvalbumin immunoreactivity in the neocortex of hypothyroid adult rats , 1996, Neuroscience Letters.

[105]  A. Cleare,et al.  Neuroendocrine evidence for an association between hypothyroidism, reduced central 5‐HT activity and depression , 1995, Clinical endocrinology.

[106]  P. Bräunig,et al.  Circadian rhythm of vital signs, norepinephrine, epinephrine, thyroid hormones, and cortisol in schizophrenia , 1995, Psychiatry Research.

[107]  W. Wiersinga,et al.  Soluble cytokine receptors and the low 3,5,3'-triiodothyronine syndrome in patients with nonthyroidal disease. , 1995, The Journal of clinical endocrinology and metabolism.

[108]  B. Künnecke,et al.  Adult-onset hypothyroidism and the cerebral metabolism of (1,2-13C2) acetate as detected by 13C nuclear magnetic resonance. , 1995, Endocrinology.

[109]  D. Brann Glutamate: a major excitatory transmitter in neuroendocrine regulation. , 1995, Neuroendocrinology.

[110]  Walch Tj Enhancing compliance in schizophrenic patients by weekly dosing with levothyroxine sodium. , 1994 .

[111]  K. A. Kadir,et al.  High Prevalence of Thyroid Function Test Abnormalities in Chronic Schizophrenia , 1994, The Australian and New Zealand journal of psychiatry.

[112]  C. Montigny,et al.  Current advances and trends in the treatment of depression. , 1994, Trends in pharmacological sciences.

[113]  T. Walch Enhancing compliance in schizophrenic patients by weekly dosing with levothyroxine sodium. , 1994, Journal of Clinical Psychiatry.

[114]  W. Wiersinga,et al.  Association between serum interleukin-6 and serum 3,5,3'-triiodothyronine in nonthyroidal illness. , 1993, The Journal of clinical endocrinology and metabolism.

[115]  A. Kaviani,et al.  Time course of altered thyroid states on 5-HT1A receptors and 5-HT uptake sites in rat brain: an autoradiographic analysis. , 1993, Neuroendocrinology.

[116]  G. Mason,et al.  L-Triiodothyronine: Is this Peripheral Hormone a Central Neurotransmitter? , 1993, Neuropsychopharmacology.

[117]  S. P. Porterfield,et al.  The role of thyroid hormones in prenatal and neonatal neurological development--current perspectives. , 1993, Endocrine reviews.

[118]  J. Agrawal,et al.  Effect of L-thyroxine and carbimazole on brain biogenic amines and amino acids in rats. , 1993, Endocrine research.

[119]  P. Hallenbeck,et al.  Characterization of myelin basic protein thyroid hormone response element and its function in the context of native and heterologous promoter. , 1992, The Journal of biological chemistry.

[120]  R. Ehrlich,et al.  Neurodevelopment in infants and preschool children with congenital hypothyroidism: etiological and treatment factors affecting outcome. , 1992, Journal of pediatric psychology.

[121]  D. Javitt,et al.  Recent advances in the phencyclidine model of schizophrenia. , 1991, The American journal of psychiatry.

[122]  G. Mason,et al.  The effects of thyroid hormones on potassium-stimulated release of 3H-GABA by synaptosomes of rat cerebral cortex. , 1991, Neuropsychopharmacology.

[123]  L. Doyle Myxoedema: Some Early Reports and Contributions by British Authors, 1873–1898 , 1991, Journal of the Royal Society of Medicine.

[124]  J. Faber,et al.  Free thyroxine and 3,3',5'-triiodothyronine levels in cerebrospinal fluid in patients with endogenous depression. , 1991, Acta endocrinologica.

[125]  P. Bräunig,et al.  Serum amino acids, central monoamines, and hormones in drug-naive, drug-free, and neuroleptic-treated schizophrenic patients and healthy subjects , 1990, Psychiatry Research.

[126]  M. Blackman,et al.  Thyroid hormone elevations during acute psychiatric illness: relationship to severity and distinction from hyperthyroidism. , 1990, Endocrine research.

[127]  J. Magliozzi,et al.  Effect of oral administration of haloperidol on plasma thyrotropin concentrations in men , 1989, Psychoneuroendocrinology.

[128]  T. Valcana,et al.  Characterization of thyroid hormone transport in synaptosomes from rat brain , 1989, Molecular and Cellular Endocrinology.

[129]  D. Gripois,et al.  Tyrosine content, influx and accumulation rate, and catecholamine biosynthesis measured in vivo, in the central nervous system and in peripheral organs of the young rat. Influence of neonatal hypo- and hyperthyroidism. , 1989, Archives internationales de physiologie et de biochimie.

[130]  J. Kennedy,et al.  Serum Thyroxine Levels in Schizophrenic and Affective Disorder Diagnostic Subgroups , 1989, Journal of Nervous and Mental Disease.

[131]  S. Southwick,et al.  Serum thyroxine change and clinical recovery in psychiatric inpatients , 1989, Biological Psychiatry.

[132]  A. Messer,et al.  Effects of mild hyperthyroidism on levels of amino acids in the developing Lurcher cerebellum. , 1989, Journal of neurogenetics.

[133]  M. Hayashi,et al.  Role of Thyroid Hormone and Nerve Growth Factor in the Development of Choline Acetyltransferase and Other Cell‐Specific Marker Enzymes in the Basal Forebrain of the Rat , 1988, Journal of neurochemistry.

[134]  C. Nemeroff,et al.  The effects of thyroid state on beta-adrenergic and serotonergic receptors in rat brain , 1987, Psychoneuroendocrinology.

[135]  H. Whiteford,et al.  TRH stimulation test and depression , 1987, Psychiatry Research.

[136]  Shikaeva Fv,et al.  [Functional interrelations of monoamines, thyrotropic hormone and thyroid hormones in hyperprolactinemia]. , 1987 .

[137]  F. V. Shikaeva,et al.  [Functional interrelations of monoamines, thyrotropic hormone and thyroid hormones in hyperprolactinemia]. , 1987, Problemy Endokrinologii.

[138]  J. Dussault,et al.  Thyroid hormones and brain development. , 1987, Annual review of physiology.

[139]  D. Overstreet,et al.  Hypothyroidism leads to incresed dopamine receptor sensitivity and concentration , 1986, Pharmacology Biochemistry and Behavior.

[140]  C. Stefanis,et al.  Effects of six weeks' neuroleptic treatment on the pituitary-thyroid axis in schizophrenic patients. , 1986, Neuropsychobiology.

[141]  G. Delong,et al.  NEUROLOGICAL SIGNS IN CONGENITAL IODINE‐DEFICIENCY DISORDER (ENDEMIC CRETINISM) , 1985, Developmental medicine and child neurology.

[142]  R. Tuominen,et al.  Effects of some putative amino acid neurotransmitters on the stimulated TSH secretion in male rats. , 1983, Hormone Research.

[143]  P. Honegger,et al.  Triiodothyronine enhancement of neuronal differentiation in aggregating fetal rat brain cells cultured in a chemically defined medium , 1980, Brain Research.

[144]  C. Stefanis,et al.  Free-thyroxine index in schizophrenic patients before and after neuroleptic treatment. , 1980, Neuropsychobiology.

[145]  M. Mitchell,et al.  Screening for congenital hypothyroidism: results of screening one million North American infants. , 1979, The Journal of pediatrics.

[146]  M. Dratman,et al.  Synaptosomal [125I]triiodothyronine after intravenous [125I]thyroxine. , 1978, The American journal of physiology.

[147]  F. Goodwin,et al.  Pituitary thyrotropin response to thyrotropin-releasing hormone in affective illness: relationship to spinal fluid amine metabolites. , 1977, The American journal of psychiatry.

[148]  P. Timiras,et al.  Effect of hypo- and hyperthyroidism on regional monoamine metabolism in the adult rat brain. , 1977, Neuroendocrinology.

[149]  J. Axelrod,et al.  Localization of triiodothyronine in nerve ending fractions of rat brain. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[150]  R. Wurtman,et al.  THYROID STATE AND BRAIN MONOAMINE METABOLISM11 , 1975 .

[151]  R. Wurtman,et al.  Thyroid state and brain monoamine metabolism. , 1975, Endocrinology.

[152]  J. Pasquini,et al.  Hormonal regulation of brain development. 3. Effects of triiodothyronine and growth hormone on the biochemical changes in the cerebral cortex and cerebellum of neonatally thyroidectomized rats. , 1969, Brain research.

[153]  R. Balázs,et al.  BIOCHEMICAL EFFECTS OF THYROID DEFICIENCY ON THE DEVELOPING BRAIN , 1968, Journal of neurochemistry.

[154]  T. Cooper,et al.  A controlled sevn year study of endocrine and other indices in drug treated chronic schizophrenics. , 1968, Acta psychiatrica Scandinavica. Supplementum.

[155]  J. Pasquini,et al.  Hormonal regulation of brain development. II. Effect of neonatal thyroidectomy on succinate dehydrogenase and other enzymes in developing cerebral cortex and cerebellum of the rat. , 1967, Brain research.

[156]  C. Havard,et al.  Radioactive isotopes in clinical medicine. I. , 1967, British medical journal.

[157]  Alicia E. Ramírez De Guglielmone,et al.  INFLUENCE OF NEONATAL HYPOTHYROIDISM ON AMINO ACIDS IN DEVELOPING RAT BRAIN , 1966, Journal of neurochemistry.

[158]  B. Bursten Psychoses associated with thyrotoxicosis. , 1961, Archives of general psychiatry.

[159]  D. Woolley,et al.  A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERS. , 1954, Proceedings of the National Academy of Sciences of the United States of America.

[160]  R. Asher Myxoedematous Madness , 1949, British medical journal.